Immunotherapy for Head and Neck Cancer Treatment

Описание к видео Immunotherapy for Head and Neck Cancer Treatment

Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins

Комментарии

Информация по комментариям в разработке